Gprc5a depletion enhances the risk of smoking-induced lung tumorigenesis and mortality-Reference-Cited by-同舟云学术

Gprc5a depletion enhances the risk of smoking-induced lung tumorigenesis and mortality

Published:2019-06 Issue: Volume:114 Page:108791
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Guo Wenzheng,Hu Min,Wu Jingjing,Zhou Aiping,Liao Yueling,Song Hongyong,Xu Dongliang,Kuang Yanbin,Wang Tong,Jing Bo,Li Kaimi,Ling Jing,Wen Donghua,Wu Wenjuan

Funder

National Natural Science Foundation Youth Project

National Natural Science Foundation of China

Key Discipline Construction Project of Pudong Health Bureau of Shanghai

Municipal Human Resources Development Program for Outstanding Leaders in Medical Disciplines in Shanghai

Fundamental Research Funds for the Central Universities

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference38 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J. Clin.,2018

2. The importance of incorporating smoking cessation into lung cancer screening;Minnix;Transl. Lung Cancer Res.,2018

3. Smoking relapse during the first year after treatment for early-stage non-small-cell lung cancer;Walker;Cancer Epidemiol. Biomarkers Prev.,2006

4. Smoking behavior following diagnosis in patients with stage I non-small cell lung cancer;Gritz;Cancer Causes Control: CCC.,1991

5. Randomized phase III intergroup trial of isotretinoin to prevent second primary tumors in stage I non-small-cell lung cancer;Lippman;J. Natl. Cancer Inst.,2001

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A novel prognostic signature based on smoking-associated genes for predicting prognosis and immune microenvironment in NSCLC smokers;Cancer Cell International;2024-05-15

2. GPRC5A is a potential prognostic biomarker and correlates with immune cell infiltration in non-small cell lung cancer;Translational Lung Cancer Research;2024-05

3. Exploring the Role of GPRC5A Gene in Breast Cancer: Review and Prospects;Advances in Clinical Medicine;2024

4. Modulating the immune system as a therapeutic target for myelodysplastic syndromes and acute myeloid leukemia;BIOCHEM CELL BIOL;2023

5. WNT ligands in non-small cell lung cancer: from pathogenesis to clinical practice;Discover Oncology;2023-07-24